mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven TumorsClare F. Malone, Karen Cichowski, Chloe E. Emerson et al.|Cancer Discovery|2017Cited by 110
Defining Key Signaling Nodes and Therapeutic Biomarkers in <i>NF1</i> -Mutant CancersClare F. Malone, Karen Cichowski, Jody Fromm Longo et al.|Cancer Discovery|2014Cited by 64
Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancersRebecca Lock, Karen Cichowski, Rachel Ingraham et al.|Journal of Clinical Investigation|2016Cited by 43
Supplementary Figure Legends from Defining Key Signaling Nodes and Therapeutic Biomarkers in <i>NF1</i>-Mutant CancersClare F. Malone, Karen Cichowski, Ophélia Maertens et al.|Unknown|2023Cited by 0
Supplementary Figure 1 from Defining Key Signaling Nodes and Therapeutic Biomarkers in <i>NF1</i>-Mutant CancersClare F. Malone, Karen Cichowski, Ophélia Maertens et al.|Unknown|2023Cited by 0